Myosin XIX Antikörper (Middle Region)
Kurzübersicht für Myosin XIX Antikörper (Middle Region) (ABIN953575)
Target
Alle Myosin XIX (MYO19) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 561-589, Middle Region
-
Spezifität
- This antibody recognizes human MYO19.
-
Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the central region (between 561-589aa) of human MYO19.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Myosin XIX (MYO19)
-
Andere Bezeichnung
- MYO19
-
Hintergrund
- Probable S-adenosyl-L-methionine-dependent methyltransferase that catalyzes the formation of 5-methyl-uridine at position 54 (M-5-U54) in all tRNA. May also have a role in tRNA stabilization or maturation (By similarity).Synonyms: MYOHD1, Myosin head domain-containing protein 1, Myosin-XIX
-
Molekulargewicht
- 109135 Da
-
Gen-ID
- 80179
-
NCBI Accession
- NP_001028752
Target
-